TY - JOUR
T1 - Secondary structure alterations in insulin and growth hormone water-in-oil emulsions
AU - Jørgensen, Lene
AU - Vermehren, Charlotte
AU - Bjerregaard, Simon
AU - Froekjaer, Sven
N1 - Copyright 2002 Elsevier Science B.V.
PY - 2003/3/18
Y1 - 2003/3/18
N2 - Water-in-oil (w/o) emulsions have shown a promising release profile of small drug molecules and proteins. However, the major concerns are the structural stability, the retention of the activity and to avoid unwanted immunological reactions caused by the changes in protein structure. In the present study, the secondary structure of insulin and growth hormone is investigated after manufacture of w/o emulsions, using Fourier transform infrared (FTIR) spectroscopy. Initial investigations indicate an altered distribution in the secondary structure elements, e.g. alpha-helix and beta-sheet, measured by area overlap calculations. The changes are more pronounced for growth hormone than for insulin. The overlapping area is 0.93 +/- 0.01 for the emulsion containing insulin manufactured at 0 degrees C and homogenised for 3 min, the corresponding value for growth hormone is 0.83 +/- 0.01. The droplet size changes from 0.27 +/- 0.04 microm in the blank w/o emulsion to 0.79 +/- 0.13 and 0.66 +/- 0.21 microm when insulin or growth hormone is incorporated into the w/o emulsions, respectively.
AB - Water-in-oil (w/o) emulsions have shown a promising release profile of small drug molecules and proteins. However, the major concerns are the structural stability, the retention of the activity and to avoid unwanted immunological reactions caused by the changes in protein structure. In the present study, the secondary structure of insulin and growth hormone is investigated after manufacture of w/o emulsions, using Fourier transform infrared (FTIR) spectroscopy. Initial investigations indicate an altered distribution in the secondary structure elements, e.g. alpha-helix and beta-sheet, measured by area overlap calculations. The changes are more pronounced for growth hormone than for insulin. The overlapping area is 0.93 +/- 0.01 for the emulsion containing insulin manufactured at 0 degrees C and homogenised for 3 min, the corresponding value for growth hormone is 0.83 +/- 0.01. The droplet size changes from 0.27 +/- 0.04 microm in the blank w/o emulsion to 0.79 +/- 0.13 and 0.66 +/- 0.21 microm when insulin or growth hormone is incorporated into the w/o emulsions, respectively.
KW - Chemistry, Pharmaceutical
KW - Drug Delivery Systems
KW - Drug Stability
KW - Emulsions
KW - Growth Hormone/chemistry
KW - In Vitro Techniques
KW - Insulin/chemistry
KW - Mineral Oil
KW - Protein Structure, Secondary
KW - Spectroscopy, Fourier Transform Infrared/instrumentation
KW - Temperature
KW - Time Factors
U2 - 10.1016/s0378-5173(02)00668-3
DO - 10.1016/s0378-5173(02)00668-3
M3 - Journal article
C2 - 12615400
VL - 254
SP - 7
EP - 10
JO - International Journal of Pharmaceutics
JF - International Journal of Pharmaceutics
SN - 0378-5173
IS - 1
ER -